Search results
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).
- Roger Miller
- Robert Califf
Mar 30, 2010 · The drug company, Amphastar Pharmaceuticals Inc., paid more than $100,000 to Kroll, the New York-based private investigative firm, to uncover the information about Janet Woodcock, director of...
Nov 17, 2023 · WOODCOCK SET TO RETIRE — Longtime FDA regulator Janet Woodcock, who has worked at the agency since 1986, plans to retire in early 2024, FDA Commissioner Robert Califf told agency staff...
People also ask
What happened to Susan Woodcock?
When did Susan Woodcock join the FDA?
Why did Elizabeth Woodcock criticize Sarepta Therapeutics?
Nov 16, 2023 · Janet Woodcock, a top Food and Drug Administration official who had been on the short list to head the agency under President Joe Biden, will retire in early 2024 after 37 years at the regulator.
Nov 16, 2023 · November 16, 2023 at 2:31 PM EST. Updated on. November 16, 2023 at 5:19 PM EST. US Food and Drug Administration Deputy Commissioner Janet Woodcock will retire next year after nearly four...
Jan 26, 2024 · | January 26, 2024. The story of Janet Woodcock’s illustrious career is not just one of professional achievements; it’s a tale of enduring partnerships, empathetic leadership, and unwavering commitment to science and patient care that will continue as she leaves public service this year.
This Wednesday will be Dr. Janet Woodcock’s last day at the US Food and Drug Administration (FDA), capping a remarkable 38-year career at the agency. She’s been called one of the most powerful and influential drug regulators worldwide. Last Thursday, Focus sat down with Woodcock in her office at FDA’s White Oak campus, where she reflected ...
